- Home
- DOCU vs ICLR Comparison
DOCU vs ICLR Comparison
Compare DOCU & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DOCU
- ICLR
- Stock Information
- Founded
- DOCU 2003
- ICLR 1990
- Country
- DOCU United States
- ICLR Ireland
- Employees
- DOCU N/A
- ICLR N/A
- Industry
- DOCU EDP Services
- ICLR Biotechnology: Commercial Physical & Biological Resarch
- Sector
- DOCU Technology
- ICLR Health Care
- Exchange
- DOCU Nasdaq
- ICLR Nasdaq
- Market Cap
- DOCU 14.6B
- ICLR 14.3B
- IPO Year
- DOCU 2018
- ICLR 1998
- Fundamental
- Price
- DOCU $69.59
- ICLR $174.78
- Analyst Decision
- DOCU Hold
- ICLR Buy
- Analyst Count
- DOCU 17
- ICLR 15
- Target Price
- DOCU $95.62
- ICLR $211.36
- AVG Volume (30 Days)
- DOCU 3.2M
- ICLR 1.0M
- Earning Date
- DOCU 12-04-2025
- ICLR 10-22-2025
- Dividend Yield
- DOCU N/A
- ICLR N/A
- EPS Growth
- DOCU N/A
- ICLR N/A
- EPS
- DOCU 1.33
- ICLR 7.47
- Revenue
- DOCU $3,095,362,000.00
- ICLR $8,102,602,000.00
- Revenue This Year
- DOCU $9.55
- ICLR N/A
- Revenue Next Year
- DOCU $6.78
- ICLR $1.68
- P/E Ratio
- DOCU $53.01
- ICLR $23.78
- Revenue Growth
- DOCU 8.29
- ICLR N/A
- 52 Week Low
- DOCU $66.35
- ICLR $125.10
- 52 Week High
- DOCU $107.86
- ICLR $234.60
- Technical
- Relative Strength Index (RSI)
- DOCU 42.69
- ICLR 42.76
- Support Level
- DOCU $70.21
- ICLR $173.47
- Resistance Level
- DOCU $72.50
- ICLR $184.41
- Average True Range (ATR)
- DOCU 2.08
- ICLR 7.92
- MACD
- DOCU 0.37
- ICLR -1.89
- Stochastic Oscillator
- DOCU 37.68
- ICLR 5.29
About DOCU DocuSign Inc.
Docusign offers Agreement Cloud, a broad cloud-based software suite that enables users to automate the agreement process and provide legally binding e-signatures from nearly any device. The company was founded in 2003 and completed its initial public offering in 2018.
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.